Sample Release Reagent
Product nomen
Macronis & Micro-test Sample Release Reagent
Testimonium
CE, FDA, NMPA
Principalis components
Nomen | Principalis components | Componentspecifications | quantitas |
Sample Releasetenui | Dithiothreitolum, sodium dodecylsulfate (SDS), RNAse inhibitor;surfactant, aqua mundata | 0.5mL/Vial | 50 Vial |
Nota: Components in diversis batches kitis non convertuntur.
Repono conditionibus et fasciae vitae
Reponunt et transportant ad locus temperatus.Pluteae vita 24 mensium est.
Lorem instrumenta
Instrumenta et instrumenta in processui sample, ut pipettae, vorticem mixtorum;balneis aquarum, etc.
Sample requisita
Nuper collectae obiectis oropharyngeis, obiectis nasopharyngeis.
Precision
Cum hoc ornamentum ad extrahendum ab in domo incisione adhibitum est referendum CV pro 10 replicat, coefficiens variationis (CV, %) ipsius Ct valoris non plus quam 10% est.
Inter batch differentia
Cum in-domus praecisio relatio probatur in tribus batchris compendiorum sub probatione productionis repetitae extractionis et coefficiens variationis (CV, %) de Ct valoris non plus quam 10%.
Comparatio euismod
Extraction efficientiam comparationis
Comparatio efficientiae globuli magneticae methodi et specimen remissionis | ||||
coniunctis | magnetica globuli modum | sample releaser | ||
orfab | N | orfab | N | |
20000 | 28.01 | 28.76 | 28.6 | 29.15 |
2000 | 31.53 | 31.9 | 32.35 | 32.37 |
500 | 33.8 | 34 | 35.25 | 35.9 |
200 | 35.25 | 35.9 | 35.83 | 35.96 |
100 | 36.99 | 37.7 | 38.13 | undet |
Extractio efficientia dimissi exempli gratiarum similis erat methodo globuli magneticae, et rectio pathogeni 200Copies/mL esse potuit.
CV valorem comparationis
Repetitabilitas sample release extraction | ||
concentratio: 5000Copies/mL | ORF1ab | N |
30.17 | 30.38 | |
30.09 | 30.36 | |
30.36 | 30.26 | |
30.03 | 30.48 | |
30.14 | 30.45 | |
30.31 | 30.16 | |
30.38 | 30.7 | |
30.72 | 30.79 | |
CV | 0.73% | 0.69% |
Cum probata in 5000 exemplaria /mL, CV orFab et N erat 0.73% et 0,69%, respective.